alendronate and Cafe-au-Lait Spots with Pulmonic Stenosis studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Research Excerpts

Excerpt	Relevance	Reference
"This is the first prospective follow-up study to describe the effects of oral alendronate medication on neurofibromatosis 1 (NF1)-related osteoporosis."	9.19	Follow-up of six patients with neurofibromatosis 1-related osteoporosis treated with alendronate for 23 months. ( Heervä, E; Huilaja, L; Leinonen, P; Peltonen, J; Peltonen, S, 2014)
"This is the first prospective follow-up study to describe the effects of oral alendronate medication on neurofibromatosis 1 (NF1)-related osteoporosis."	5.19	Follow-up of six patients with neurofibromatosis 1-related osteoporosis treated with alendronate for 23 months. ( Heervä, E; Huilaja, L; Leinonen, P; Peltonen, J; Peltonen, S, 2014)
"In addition, persons with high bone resorption in vitro on average had high levels of serum CTX."	1.38	Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro. ( Aro, HT; Heervä, E; Peltonen, J; Peltonen, S; Svedström, E; Väänänen, K, 2012)

Research

Studies (2)

Authors

Trials

Other Studies

1 other study available for alendronate and Cafe-au-Lait Spots with Pulmonic Stenosis

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Heervä, E	2
Huilaja, L	1
Leinonen, P	1
Peltonen, S	2
Peltonen, J	2
Svedström, E	1
Aro, HT	1
Väänänen, K	1